Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Find out which credit card offers the best rewards and start earning more on your purchases. Compare your options now.
24,094 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
This deep-dive analyzes redwire (rdw) 2026 earnings potential, examining revenue outlook, contracts, and the catalyst...
The space-launch landscape is shifting as Blue Origin faces a setback. This could paradoxically amplify SpaceX's IPO ...
Intel’s stock whipsawed after a dramatic breakout, triggering a deeper look at whether the move can sustain amid AI d...
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
Peloton reports fresh restructuring amid a stubborn demand slump and rising costs. The destruction peloton continues ...
A family estate in a hot real estate market yields a six-figure tax surprise when an inherited home’s stepped-up basi...
Chips led a broad market dip at midday as investors weighed AI headlines against inflation risks and possible rate hi...
Salesforce leans on a sweeping buyback to defend its core, while ServiceNow expands through acquisitions focused on s...
Meta Platforms’ AI push is reshaping sentiment around NVIDIA. This article breaks down what that means for NVIDIA sto...
SoundHound AI faced a sharp stock move after a major leadership change. This article breaks down what happened, why i...